Skyscape Web Viewer : Yao & Artusio's Anesthesiology: Problem-Oriented Patient Management : Medication Index

View All
T4 1.C.7 30.C.2 63.C.7 29.C.4 63.C.11 9.C.2
Tacrolimus 13.D.10 16.D.4 23.A.7 25.B.3 53.A.7 13.E.9 16.D.6 25.A.9 25.D.2 Adverse Effects of Immunosuppressant Medications
Tapentadol
Tenormin
Terazosin 22.B.2 48.B.14
Terbutaline
Tetanus toxoid
Tetracaine Physiochemical Properties of Commonly Used Local Anesthetics 48.C.2
Theophylline 1.B.14 2.C.13
Thiamine
Thrombin
Thyroxine
Ticlopidine 24.B.5 51.A.13 24.B.6
Timolol 34.A.7 34.A.10
Tirofiban 5.C.II-26 51.A.13
Tissue plasminogen activator 16.A.10 21.D.7 Changes of the Coagulation and Fibrinolytic System in Esld 21.B.4 31.A.4
Tolazamide
Tolbutamide
Toradol
Tramadol 49.B.11 17.D.2 63.B.5
Trandate
Tranexamic acid 16.C.17 27.C.7 5.C.I-17 58.C.16 Cardiac Anesthesia Intravenous Medications 13.C.3 20.B.9 31.B.11 57.C.24 9.C.11
Tranylcypromine
Triiodothyronine
Trimethoprim 4.D.1 39.C.4
Tromethamine 27.C.6 16.C.16
Tubocurarine 55.B.3 57.C.5 The Metabolism, Elimination, and Histamine Release of Muscle Relaxants 56.C.12 Characteristics of Commonly Used Muscle Relaxants
T3
Tazobactam
Tensilon